Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

AIMS/HYPOTHESIS: To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a serum potassium change on renal outcomes in patients with type 2 diabetes and nephropathy. METHODS: We performed a post hoc analysis in patients with type 2 diabetes participating in...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, B. M., Cooper, M. E., Parving, H-H., Shahinfar, S., Grobbee, D., de Zeeuw, D.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995871/
https://www.ncbi.nlm.nih.gov/pubmed/20882268
http://dx.doi.org/10.1007/s00125-010-1922-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995871/
https://www.ncbi.nlm.nih.gov/pubmed/20882268
http://dx.doi.org/10.1007/s00125-010-1922-6

Ejemplares similares